GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Renovaro Inc (STU:2Q5) » Definitions » Interest Income

Renovaro (STU:2Q5) Interest Income : €0.02 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Renovaro Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Renovaro's interest income for the three months ended in Dec. 2023 was €0.02 Mil. Its interest income for the trailing twelve months (TTM) ended in Dec. 2023 was €0.02 Mil.

Renovaro Interest Income Historical Data

The historical data trend for Renovaro's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renovaro Interest Income Chart

Renovaro Annual Data
Trend Mar13 Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.04 0.01 0.12 -

Renovaro Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.01 0.02

Renovaro Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renovaro (STU:2Q5) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Renovaro Inc (STU:2Q5) » Definitions » Interest Income
Comparable Companies
AEON SCPH INZY ENTA MCRB IVVD GRTS DNTH CBUS PSTX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
RENB:USA
Address
2080 Century Park East, Suite 906, Los Angeles, CA, USA, 90067
Website
https://www.enochianbio.com
Renovaro Biosciences Inc Formerly Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.

Renovaro (STU:2Q5) Headlines

No Headlines